Over the past few years, checkpoint blockade immunotherapies have revolutionized cancer treatment and helped many patients who were previously considered untreatable. Now, discoveries made by two Cancer Research Institute scientists could help make...
7-Mar-2017 2:05 PM EST Add to Favorites
Cancer Research Institute Awards Grant to Develop Powerful Genomic Data Resource for Cancer Immunotherapy Researchers
Three nonprofits partner to create powerful database that will aim to improve immunotherapy for many types of cancer.
31-Jan-2017 6:00 AM EST Add to Favorites
This Saturday [Dec 3], the 58th Annual Meeting of the American Society of Hematology will begin in San Diego, where the latest advances in research for blood cancers including leukemia, lymphoma, and myeloma will be highlighted during the four days...
12-Dec-2016 11:05 AM EST Add to Favorites
Cancer Research Institute and Fibrolamellar Cancer Foundation Announce Partnership to Fund Cancer Immunotherapy Research in Ultra-Rare Liver Cancer
Two nonprofits team up to fund immunotherapy research designed to benefit patients with an ultra-rare form of liver cancer.
6-Dec-2016 6:00 AM EST Add to Favorites
Parker Institute for Cancer Immunotherapy and Cancer Research Institute Launch Collaboration on Cancer Neoantigens
New collaboration between two nonprofits focused on cancer immunotherapy aims to identify new DNA-based targets for personalized cancer treatments
1-Dec-2016 6:00 AM EST Add to Favorites
Cancer Research Institute to Honor Amgen for Advancing Cancer Immunotherapy Treatments and Patient Education
Nonprofit devoted to cancer immunotherapy will honor the biotech company Amgen for its contributions to cancer immunotherapy treatment and patient education
29-Aug-2016 12:00 PM EDT Add to Favorites
Four leading cancer research organizations will host a conference dedicated to the latest in cancer immunotherapy.
15-Aug-2016 12:05 PM EDT Add to Favorites
Media are encouraged to register to attend the second annual International Cancer Immunotherapy Conference organized by the Cancer Research Institute, Association for Cancer Immunotherapy, European Academy of Tumor Immunology, and the American...
3-Aug-2016 12:00 PM EDT Add to Favorites
The FDA announced on Aug 4 2009 that tumor necrosis factor (TNF) blockers used in the treatment of immune disorders carry an increased risk of lymphoma and other cancers in children and adolescents. The discoverer of TNF-alpha, Lloyd J. Old, M.D., a...
7-Aug-2009 9:00 AM EDT
Dendreon's PROVENGE for the treatment of advanced prostate cancer is the first active cellular immunotherapy to prolong patient survival, according to data from a pivotal phase III clinical trial announced at yesterday's AUA annual meeting in...
29-Apr-2009 11:20 AM EDT